Cancer, biomedical science leaders strive to improve workforce diversity
FDA launches tobacco use prevention campaign targeting multicultural youth
Early-stage prostate cancer, PSA screening rates decline
Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer
Pricey pills for an even pricier problem
Treatment of muscle-invasive bladder cancer: A systematic review
Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis
Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap?
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors
Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies
Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience
Baseline dietary glutamic acid intake and the risk of colorectal cancer: The Rotterdam study
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer
Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors
Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship
Health-related quality of life and health care use in cancer survivors compared with patients with chronic diseases
Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer
Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer
Erratum: Long-term quality of life among Dutch prostate cancer survivors